Skip to content

A survey of treatment goals and mutual understanding between patients and physicians in terms of the treatment of rheumatoid arthritis

A survey of treatment goals and mutual understanding between patients and physicians in terms of the treatment of rheumatoid arthritis - A survey of treatment goals and mutual understanding between patients and physicians in terms of the treatment of rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044463
Enrollment
500
Registered
2021-06-11
Start date
2021-06-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Sponsors

Others Eisai Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A) Patients survey Include patients eligible for the all following criteria from patients registered in MHP: (i) Patients with history of diagnosis with RA; (ii) Patients currently prescribed with medications for RA. B) Physicians survey Include physicians eligible for the all following criteria: (i) Physicians who work in any following department: rheumatology, general internal medicine, orthopedics; (ii) Physicians who have more than 4 patients with RA at the date of the survey.

Exclusion criteria

Exclusion criteria: A) Patients survey Exclude patients with any one following criteria: (i) Patients who work for any of the following organizations - market research companies - media companies - advertising companies - hospitals or clinics - pharmaceutical companies - pharmaceutical wholesalers (ii) Patients with any one following criteria - without history of medical treatment for RA - with history of medical treatment for RA which is withdrawn - with history of medical treatment for RA which is determined B) Physicians survey Exclude physicians without any one inclusion criteria.

Design outcomes

Primary

MeasureTime frame
The differences between the importance of treatment goals in patients, that in physicians, and that in patients understood by physicians.

Secondary

MeasureTime frame
- The difference between the importance of treatment goals in patients and the importance of inhibition of joint destruction for achieving goals, - The difference between the importance of treatment goals in patients and goals presented by physicians, - The difference between information that patients want to express to physicians, that patients expressed to physicians, and that were presented by physicians, - The difference between information that patients expressed to physicians and that physicians asked to patients, - The difference between consent of patients and and consent of patients that physicians understand to goals presented by physicians, - The difference between satisfaction of patients to goals presented by physicians and consent of patients that physicians understand, - The factors associating with satisfaction and consent of patients, - The difference between the importance of long-term and short-term treatment goals in patients, - The difference between the importance of long-term and short-term treatment goals in physicians.

Countries

Japan

Contacts

Public ContactEriko Wakita

Medilead Inc. Marketing Intelligence Dept.

e_wakita@medi-l.com03-6859-2295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026